Experimental drug studied for rare gut tumors, but trial halted early
Disease control
Terminated
This study tested an experimental drug called entinostat in 5 people with advanced abdominal neuroendocrine tumors that had stopped responding to standard treatments. The goal was to see if the drug could shrink tumors or slow their growth. The trial was terminated early, so resu…
Phase: PHASE2 • Sponsor: Antonio Fojo • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC